📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-12 19:42
18 analysed today
FollowTelegram
18
Today
149,969
All-time analysed
42,992
Positive
6,669
Negative
91,598
Neutral
8,642
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
2 announcements match the current filters (relevance ≥ 5).
Sharma East India Hospitals Approves Q1 FY27 Unaudited Financial Results
Sharma East India Hospitals & Medical Research Ltd has approved its unaudited financial results for the quarter ended June 30, 2026. The statutory auditors, Gopal Sharma & Co., issued a limited review report with no material qualifications or misstatements. While the specific P&L figures for the current quarter were not detailed in the provided extract, the company enters this period with a TTM revenue of Rs 36 Cr and a PAT of Rs 1 Cr. Investors should monitor if the company recovers from the sequential revenue dip seen in March 2026 (Rs 7.47 Cr) compared to previous quarters.
Confidence: MEDIUM
What changedThe company has formally approved and submitted its financial performance report for the first quarter of the 2026-27 fiscal year.
Why it mattersAs a small-cap healthcare provider with Rs 36 Cr annual revenue, quarterly performance is critical to track if the company can improve its low net profit margins (currently ~3.4% TTM).
Quarter Ended: 30-06-2026TTM Revenue: Rs 36 CrPrevious Quarter Revenue (Mar 2026): Rs 7.47 CrYear-ago Quarter Revenue (Jun 2025): Rs 9.47 CrNet Worth: Rs 14 Cr
📅 Short termThe stock may remain neutral as the filing is a routine regulatory requirement and the provided extract lacks specific growth surprises.
📈 Long termThe company's long-term value depends on its ability to scale revenue beyond the current Rs 30-36 Cr range and improve its ROCE of 11.6%.
⚠ Risk flags
- Small-cap liquidity risk
- Stagnant promoter holding
- Low net profit margins
Key Highlights
Board approval of unaudited standalone financial results for the quarter ended June 30, 2026.
Limited Review Report issued by Gopal Sharma & Co. on August 12, 2026, with a clean opinion.
Company reported a TTM revenue of Rs 36 Cr as of the previous fiscal year end.
Promoter holding remains stable at 53.63% as per the latest available context.
The company maintains a moderate Debt-to-Equity ratio of 0.53 based on a net worth of Rs 14 Cr.
👀 What to Watch
Investors should examine the full P&L statement to check for revenue recovery, as the March 2026 quarter (Rs 7.47 Cr) was significantly lower than the June 2025 quarter (Rs 9.47 Cr).
Sharma East India Hospitals Approves Q1 FY27 Unaudited Financial Results
The Board of Directors of Sharma East India Hospitals approved the standalone un-audited financial results for the quarter ended June 30, 2026, in a meeting held on August 12, 2026. The statutory auditors, Gopal Sharma & Co., provided a limited review report with no qualifications or material misstatements noted. This follows a trailing twelve-month (TTM) revenue of Rs 36 Cr and a PAT of Rs 1 Cr. Investors should monitor the detailed P&L to see if the company maintains its 10.1% operating margin.
Confidence: HIGH
What changedThe company has formally approved and released its financial performance data for the first quarter of the 2026-27 fiscal year.
Why it mattersQuarterly results are the primary indicator of operational health for this small-cap healthcare provider, which has a relatively high debt-to-equity ratio of 0.53.
Quarter ended: 30.06.2026TTM Revenue: Rs 36 CrTTM PAT: Rs 1 CrNet Worth: Rs 14 CrDebt-to-Equity: 0.53
📅 Short termNeutral impact expected until the market parses the specific growth numbers in the full financial statement compared to previous quarters.
📈 Long termLimited; routine quarterly reporting for a small-cap entity with stable promoter holding.
⚠ Risk flags
- Small scale of operations
- Low liquidity in the stock
Key Highlights
Board meeting held on August 12, 2026, concluded at 6:45 PM IST.
Approval of Ind-AS compliant standalone results for the quarter ended June 30, 2026.
Limited Review Report issued by Gopal Sharma & Co. with a clean opinion.
Company operates with a TTM revenue base of Rs 36 Cr and a net worth of Rs 14 Cr.
Promoter holding remains stable at 53.63% as per latest available data.
👀 What to Watch
Compare the Q1 FY27 revenue and profit figures against the June 2025 quarter (Revenue: Rs 9.47 Cr, PAT: Rs 0.32 Cr) to identify year-on-year growth trends.
